Spaulding Clinical Research, LLC Expands Clinical Pharmacology Capabilities

July 1st, 2015 - West Bend, WI, USA -  Spaulding Clinical Research, LLC (SCR), a leading global biopharmaceutical services provider, today announced that the Company had completed an expansion of their Clinical Pharmacology Unit located in West Bend, WI in order to meet growing client demand for expertise-based studies in the early phases of clinical development.

“As biopharmaceutical companies have been conducting more Phase I and Proof-of-Concept studies with increasing complexity, SCR has been well positioned to meet their needs. In this regard, we are a top provider of expertise-based Phase I services and have more than 200 beds, which is among the largest capacities for a single CRO research unit in the world,” said Cassandra Erato, Chief Operating Officer. “With our expansion complete, we are uniquely positioned to provide our customers with a level of flexibility that most units cannot.”

Spaulding Clinical Receives CRO Leadership Awards

Spaulding Clinical is a 2014 CRO Leadership Award Winner

Clinical Research Leader, Spaulding Clinical, receives CRO Leadership Awards in Quality, Innovation, Productivity, and Regulatory
 
Spaulding Clinical Research, LLC. ("Spaulding Clinical"), a recognized leader in Clinical Research and Device Manufacturing, announced that it has received CRO Leadership Awards in the following categories: Quality, Innovation, Productivity and Regulatory.

DPharm Disruptive Innovator of the Year Announced

The partnership between Medidata Solutions and Spaulding Clinical Research is chosen as the winner of DPharm“American Idol”

October 2, 2013 New York, New York: Medidata Solutions and Spaulding Clinical Research were honored with the title of Disruptive Innovator of the Year at the Dpharm Disruptive Innovations conference on September 20, 2013 for their collaboration on a novel study evaluating the impact of mobile and cloud-based technology on patient engagement for improved health outcomes in the diabetes community.